The application of a prognostic factor analysis for Ta.T1 bladder Cancer in routine urological practice
- 1 May 1995
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 75 (5), 604-607
- https://doi.org/10.1111/j.1464-410x.1995.tb07417.x
Abstract
Objective To assess the reproducibility of the prognostic factor findings of Parmar et al. [1], in a routine urological practice. Patients and methods The superficial tumour recurrence-free rate has been analysed for 232 newly diagnosed consecutive patients with Ta. Tl transitional cell carcinoma of the bladder. All patients were without carcinoma in situ or muscle invasion at the time of diagnosis. Results Applying the prognostic factors recommended (number of tumours at diagnosis; tumour recurrence at first 3-month cystoscopy) patients with Ta. Tl bladder Cancer may be divided into three distinct groups with significantly different chances of superficial bladder tumour recurrence. Conclusion Two simple clinical criteria provide a reliable guide to the likelihood of tumour recurrence in patients with Ta. Tl bladder cancer. The modification of follow-up cystoscopy schedules on this basis requires prospective study.Keywords
This publication has 5 references indexed in Scilit:
- Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapyBMJ, 1994
- Prognostic Factors for Recurrence and Followup Policies in the Treatment of Superficial Bladder Cancer: Report from the British Medical Research Council Subgroup On Superficial Bladder Cancer (Urological Cancer Working Party)Journal of Urology, 1989
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- The Effect of Intravesical Thiotepa on the Recurrence Rate of Newly Diagnosed Superficial Bladder Cancer. An MRC StudyBritish Journal of Urology, 1985
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977